Tech Company Financing Transactions
One Biosciences Funding Round
One Biosciences closed a $17.5 million Series A financing round on 7/17/2025. Backers included Blast, Redmile Group and Adamed Group.
Transaction Overview
Company Name
Announced On
7/17/2025
Transaction Type
Venture Equity
Amount
$17,500,000
Round
Series A
Investors
Blast (Lead Investor)
Redmile Group (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate the clinical development its flagship OneMap platform and support the scaling of strategic partnerships with pharmaceutical and biotech companies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
101 rue de Sevres
Paris, 75006
France
Paris, 75006
France
Phone
Undisclosed
Website
Email Address
Overview
One Biosciences unlocks routine analysis of tumor heterogeneity through AI-powered single-cell technologies, transforming precision medicine. Tumor heterogeneity is one of cancer's greatest challenges. We are a techbio company that brings AI-driven single-cell analysis directly into clinical practice, transforming how we understand and treat cancer. Our technology creates detailed functional profiles of patient tumors, unlocking insights that drive better clinical decision-making and accelerate precision medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ben Brahim
Chief Scientific Officer
Céline Vallot
Co-Founder
Magali Richard
Co-Founder
David Schilansky
Browse more venture capital transactions:
Prev: 7/17/2025: BQP venture capital transaction
Next: 7/17/2025: Ami Colé venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs